How coping strategy bridges the gap: Self-efficacy as a key to treatment adherence
DOI:
https://doi.org/10.57040/we4wgz79Keywords:
Adherence to treatment, Chronic patients, Coping mechanism, Self-efficacyAbstract
Chronic illness management often requires long-term adherence to treatment regimens, yet many patients struggle to maintain consistent adherence. While there is substantial evidence on the role of self-efficacy in promoting adherence, less is known about how coping strategies influence this relationship. This study investigated the mediating role of coping strategies in the relationship between self-efficacy and treatment adherence among chronic patients in Nigeria. Participants were 398 chronic patients (62% female), aged 21-65 years (M = 54.71; SD = 9.45), with conditions including hypertension (37%), dyslipidemia (31%), diabetes (20%), and COPD (12%). They responded to the Chronic Pain Self-Efficacy Scale, the Brief-COPE Inventory, and the Morisky Medication Adherence Scale. Following the mediation framework proposed by Baron and Kenny (1986), a series of regression analyses were conducted. Results of data analysis showed that self-efficacy was significantly associated with treatment adherence ((B = 0.58, β = .42, p < .001). Coping strategies were significantly associated with treatment adherence (B = 0.47, β = .38, p < .001). Findings also indicated that coping strategies served as a pathway through which self-efficacy was linked to adherence (B = 0.28, β = .18, p < .001). These findings suggest that adaptive coping strategies not only directly improve adherence but also enhance self-efficacy, which further promotes adherence. The study highlights the importance of addressing both coping strategies and self-efficacy in interventions aimed at improving treatment adherence among chronic patients.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Uwemedimo Sunday Isaiah, Abraham Terfa Naibo, Emekubong Nathan Udookuk, Mbuotidem Emmanuel Ekerette, Samson Ogwuche

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.